Rench Wealth Management, Inc. Gilead Sciences, Inc. Transaction History

Rench Wealth Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.11 Million - $2.33 Million	-33,787 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $59,085 - $66,257	955 Added 2.91%	33,787 $2.28 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $106,050 - $118,804	-1,696 Reduced 4.91%	32,832 $2.13 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $138,091 - $180,199	2,281 Added 7.07%	34,528 $2.16 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $81,544 - $90,284	1,144 Added 3.68%	32,247 $2.49 Million

Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $20,112 - $23,460	-310 Reduced 0.99%	31,103 $2.2 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $59,437 - $72,460	-816 Reduced 2.53%	31,413 $2.37 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $140,378 - $164,784	1,973 Added 6.52%	32,229 $2.31 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.18 Million - $2.59 Million	30,256	30,256 $2.45 Million

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rench Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Rench Wealth Management, Inc. with notifications on news.